The European public health and blood authorities responded to the threat posed by West Nile virus to blood safety of blood and blood components by adopting preventive measures which are defined in the EU blood legislation, professional guides of the Council of Europe and the EU WNV blood transfusion preparedness plan. The measures include the deferral of blood donors that have visited or residing in a NUTS 3 area considered to be affected (i.e. with at least one confirmed case).
Online directory with training courses on the prevention and control of antimicrobial resistance and healthcare-associated infections, published by countries and organisations
The conference addressed long-term effectiveness HIV of drugs, co-infections with tuberculosis or viral hepatitis and other co-morbidities, and most inequitable access to care across Europe
The main objective of the course was to strengthen capacity in EU Member States for control of healthcare-associated infections due to multidrug-resistant organisms (MDROs) in acute health care settings and to promote the broadest possible implementation of appropriate methods. A second objective was to achieve team building between colleagues with similar responsibilities in control of nosocomial spread of MDROs and to share training approaches, knowledge and best practices.
The ninth Healthcare Infection Society (HIS) International Conference was a three-day conference focussing on infection prevention and control, organised by the HIS in collaboration with the French Society of Hospital Hygiene (SF2H). The conference programme covered a range of key topics such as epidemiology, surveillance, information technology in infection prevention and control, decontamination, blood borne viruses, antimicrobial resistance and rapid diagnostic methods.
The aims of the meeting were to enable sharing of experiences and good practices between member states, review ECDC’s current programme of work and to help determine future priorities for surveillance, prevention and control of the hepatitis B virus (HBV) and hepatitis C virus (HCV) across Europe.